Med Ed 101

MAY 28, 2025

What a waste […] The post Uniform MPJE From NABP – Coming In 2026 appeared first on Med Ed 101. I have licenses in 3 states and that is plenty for me to keep track of. Some pharmacists are having to obtain double-digit licenses to perform their role as a pharmacist.

59

59

Putting Patients First Blog

APRIL 10, 2025

NHC Statement on Fiscal Year 2026 Federal Health Care Funding NHC Statement on Fiscal Year 2026 Federal Health Care Funding (PDF) Prepared written testimony for Kimberly Beer Senior Vice President, Policy and External Affairs, National Health Council U.S.

59

59

STAT

SEPTEMBER 6, 2023

29, Medicare released its highly anticipated list of 10 therapies for which it plans to establish a price by 2026.

Biosimilars 325

Biosimilars Drug Pricing 325

The Pharmacist

NOVEMBER 1, 2023

Vaccination regulations adopted due to the Covid pandemic will be extended until 2026 following a Government consultation. Ministers will extend the regulations until 1 April 2026 to support the supply, distribution and administration of Covid and flu vaccines as the country transitions out of the pandemic.

Vaccines 105

Vaccines 105

The Pharmacist

SEPTEMBER 11, 2024

Slow progress on the community pharmacy prescribing pathfinder project has sparked concerns that a viable commissioned community pharmacy prescribing service will not be ready by 2026, The Pharmacist has learned.

Community Pharmacies 105

Community Pharmacies 105

STAT

AUGUST 13, 2024

In a press release, the company said that the cuts would help it extend its cash reserves from the second half of 2026 into 2028. The Bay Area biotech brought in $32 million during the quarter but also reported a net loss of $1.6 Continue to STAT+ to read the full story…

355

355

pharmaphorum

OCTOBER 24, 2024

Denmark's Lundbeck has said that efforts to build its R&D portfolio are on track to deliver four new molecular entities (NMEs) in phase 3 trials in 2026, including an epilepsy drug from its recently announced $2.6 billion takeover of Longboard Pharma.

105

105

PharmaVoice

OCTOBER 23, 2024

As Sanofi prepares to halt production on its dengue vaccine in 2026, locally acquired infections in the U.S. are raising the alarm.

Vaccines 246

Vaccines 246

European Pharmaceutical Review

SEPTEMBER 12, 2023

Over 50 percent of respondents answered that machine learning for optimisation of manufacturing processes will be the technology that will be used routinely in the pharmaceutical industry by 2026. The post AI to revolutionise drug development by 2026 appeared first on European Pharmaceutical Review.

Drug Development 105

Drug Development Pharmaceutical Companies Pharmaceutical Companies 105

STAT

OCTOBER 9, 2024

The Congressional Budget Office estimates that 29 million beneficiaries would qualify for weight loss drugs in 2026.    Drugs for those conditions already exist, and they’re often generic. But a lot of people are switching to GLP-1s.   Continue to STAT+ to read the full story…

Diabetes 325

Diabetes 325

The Pharmacist

NOVEMBER 26, 2024

Pharmacists have been urged to continue to promote the importance of folic acid supplementations following news that it will be added to non-wholemeal flour from the end of 2026.

116

116

STAT

SEPTEMBER 23, 2024

Though the DEA is currently contemplating new regulations that would roll back many of the pandemic-era flexibilities, the lawmakers’ new bill would likely extend the current rules through 2026, according to two lobbyists familiar with the effort.  

Controlled Substances 322

Controlled Substances 322

Putting Patients First Blog

JULY 1, 2025

NHC and CMSS Comments on Proposed Fiscal Year 2026 Budget Cuts (PDF) July 1, 2025 The Honorable Mike Johnson The Honorable Hakeem Jeffries Speaker Minority Leader U.S. www.cmss.org The post NHC and CMSS Submits Comments on Proposed Fiscal Year 2026 Budget Cuts appeared first on National Health Council. House of Representatives U.S.

59

59

Express Pharma

SEPTEMBER 23, 2024

Gupta has been elected as the National President of the Indian Pharmaceutical Association (IPA) for the term 2024-2026. Dr Gupta’s term will run from October 1, 2024 to 30th September 2026. gupta elected National President of Indian Pharmaceutical Association for 2024-2026 term appeared first on Express Pharma. The post Dr R.

Community Pharmacies 105

Community Pharmacies Hospitals 105

STAT

SEPTEMBER 20, 2024

The new guidance will affect nearly 6,000 universities and other institutions with projects funded by HHS, which have until 2026 to comply.

329

329

STAT

FEBRUARY 14, 2025

trillion between 2026 and 2035. There is a lot of pressure to make big cuts to government spending. The Treasury Department estimates that renewing the expiring individual and estate tax provisions would cost $4.2 A group of nine Senate Republicans, including Majority Leader John Thune (S.D.)

329

329

STAT

APRIL 16, 2024

It would carve grocers, restaurants, and food warehouses out of a major portion of the FDA’s rules, which are meant to help regulators quickly track down the cause of a foodborne outbreak, and it would delay enforcement of the entire food safety program, slated to begin in 2026, by several years.

349

349

STAT

FEBRUARY 1, 2024

  The negotiated prices won’t take effect until 2026.  The Biden administration will publish the final prices by Sept. 1 of this year after the negotiation process ends.    Continue to STAT+ to read the full story…

Drug Pricing 312

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 312

European Pharmaceutical Review

AUGUST 19, 2022

billion by 2026. percent between 2021 and 2026 (the forecast period). Billion by 2026, achieving a 5.6 billion by 2026, as contract manufacturing organisations increasingly adopt newer and efficient ways to package products, increasing demand for new machinery. billion by the year 2026. Within the $130.2

Packaging 98

Packaging Compounding 98

Pharmaceutical Technology

JUNE 19, 2025

BioOrbit aims to kick off pre-clinical trials to study protein crystals for monoclonal antibodies (mAbs) produced in a pharmaceutical factory in space in 2026. Then, we will need to run pre-clinical trials of these crystals, which will be in 2026 or 2027. Image credit: Rini. com/ Shutterstock.

Communication 52

Communication Hospitals Pharmaceutical Manufacturing Packaging 52

STAT

SEPTEMBER 4, 2024

The sites are expected to employ another 90 people and open by 2026.  The pharmaceutical giant will spend more than $200 million to construct the new facility in Carlsbad, Calif., and expand its site in Indianapolis, representatives told STAT exclusively.

Drug Development 288

Drug Development 288

Express Pharma

APRIL 8, 2025

Steris Healthcare, a pharmaceutical company headquartered in Mumbai with operations in Navi Mumbai, has unveiled a 50 crore growth strategy aimed at expanding its manufacturing capacity, entering new regional markets, and launching an Initial Public Offering (IPO) in FY 202627.

Pharmaceutical Companies 63

Pharmaceutical Companies Pharmaceutical Companies 63

Express Pharma

APRIL 2, 2024

GS Krishnan, President of Association of Biotechnology Led Enterprises (ABLE) has been re-elected for another two-year term from April 2024 – 2026. The post GS Krishnan re-elected ABLE President for 2024 -2026 appeared first on Express Pharma.

105

105

STAT

SEPTEMBER 8, 2023

The negotiation, informed by confidential data from manufacturers and analysis by the Centers for Medicare and Medicaid Services, will result in a maximum fair price for each drug, which will be announced Sept. 1, 2024, and will take effect Jan. The Congressional Budget Office has estimated that the negotiations could save Medicare about $3.7

Drug Pricing 308

Drug Pricing 308

STAT

SEPTEMBER 12, 2023

The cuts extend the company’s cash runway into 2026. It also plans to allocate less money to a couple of drug candidates, including one that is currently on hold with the Food and Drug Administration. The company was formed in 2021 when the team behind Bluebird Bio decided to split its drug pipeline down the middle.

339

339

STAT

JUNE 18, 2024

Freespira CEO Joe Perekupka told STAT the company believes it will break even by the end of 2025 and will become cash flow positive in 2026. Perekupka said Freespira hopes to enroll 2,500 people in its treatment this year — twice last year’s sales — and to double its patients again in 2025 and 2026.

257

257

STAT

OCTOBER 31, 2023

As Medicare prepares to negotiate prices for its first batch of medicines, an advocacy group argues the agency should factor in controversial patent maneuvers for one drug that will have cost the program nearly $2 billion in additional spending by 2026.

Drug Pricing 315

Drug Pricing 315

Drug Channels

APRIL 24, 2025

After a blockbuster inaugural event and tremendous feedback from attendees, were excited to announce that the Drug Channels Leadership Forum (DCLF) returns on March 1618, 2026 , at the Turnberry Resort & Spa in Miami. Join us at DCLF 2026 Invitations will begin going out in October 2025. GET STARTED Be part of the conversation!

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing 52

STAT

JUNE 24, 2024

But that deal, though eventually closed, was scuttled by regulatory issues in both the U.S. and Europe, and European regulators forced Illumina to spin Grail back out. Grail now says it expects to file for full approval in the U.S. In the meantime, the company is running an annual loss of about $500 million a year.

311

311

STAT

OCTOBER 3, 2022

1, 2026, opening up JAMA’s or Nature’s website, and being able to read any article for free. Most people who heard the news likely envisioned making a cup of coffee on Jan. Read the rest…

246

246

STAT

OCTOBER 8, 2024

The latest effort involves tripling the annual supply of the drug, a long-acting medication known as cabotegravir, in hopes of making more than 2 million doses available during 2025 and 2026.

Drug Pricing 285

Drug Pricing 285

PharmaVoice

MARCH 11, 2025

Emalex Biosciences is full steam ahead with a targeted 2026 approval and launch for its novel drug.

179

179

STAT

JUNE 11, 2024

Lightpath Metabolic, expected to be available in 2026, will not only include programs for people with type 1 and type 2 diabetes and hypertension — as the current iteration of Onduo does — but will also offer GLP-1 drug prescriptions.

Diabetes 308

Diabetes 308

STAT

OCTOBER 11, 2023

The decision meant that data from roughly half of the trial were scrapped, which delayed their plans to seek regulatory approval for the shot until 2026, instead of 2025. Pfizer and Valneva maintained there were no safety issues or adverse events prompting the decision, and instead blamed unspecified problems with the conduct of the study.

Vaccines 275

Vaccines 275

STAT

AUGUST 30, 2023

Department of Health and Human Services named 10 medicines that will be subject to price negotiations for the Medicare program in 2026, a milestone and a point to start appraising the impact of the law , STAT explains. Have a wonderful day, and please do stay in touch. … On Tuesday, the U.S. The landscape here is complicated.

Biosimilars 256

Biosimilars Drug Pricing 256

Express Pharma

DECEMBER 26, 2024

The site and product dossier approvals are expected to be received by the end of 2026. As part of this initiative, Akums Group will initiate the European approval process for its oral liquid manufacturing facility, leveraging this approval to produce the contracted products.

105

105

Beckers Hospital Review

JUNE 30, 2025

According to a January Bloomberg report, UPS Healthcare generated $10 billion in revenue in 2023 and aims to double this by 2026, with other investments. The deal is part of UPS’ strategy to pivot from traditional parcel delivery to high-growth sectors.

Hospitals 105

Hospitals 105